CanSino to test coronavirus vaccine candidate in Argentina and Chile


FILE PHOTO: A volunteer receives an injection from a medical worker from Chinese pharmaceutical company CanSino Biologics Inc. for a late stage-trial against the coronavirus disease (COVID-19), in Oaxaca, Mexico November 6, 2020.REUTERS/Jorge Luis Plata

BEIJING (Reuters) - CanSino Biologics Inc will start testing its coronavirus vaccine candidate in late-stage human trials in Argentina and Chile, the co-founder of the Chinese pharmaceutical company said on Saturday.

The candidate Ad5-nCoV, which goes by the trade name Convidecia, uses a harmless common cold virus to carry genetic information of coronavirus' protein to elicit immune responses, has already begun Phase III trials in Pakistan, Russia and Mexico.

CanSino will begin interim analysis of the late-stage trial results when 50 infection cases are found, said Zhu Tao, who is also the company's chief scientific officer.

The 50-case milestone could be hit faster than previously expected judging from how the virus is spreading, Zhu told an industry event, without specifying when the analysis would start.

The expectation follows announcements this month by Pfizer Inc and BioNTech and Moderna, as well as from Russia, that their experimental vaccines are more than 90% effective, according to interim data from large trials.

China has five home-grown candidates currently undergoing Phase III trials. None have so far produced interim results.

CanSino said in June that Convidecia, which is being co-developed with a research institute affiliated to China's military, had been approved for use in military personnel.

Many military personnel, including peacekeepers in places where COVID-19 remains, have taken the vaccine and none have been infected, CanSino chief executive Yu Xuefeng told a healthcare forum on Friday.

Yu said he "has great confidence" in the product, but cautioned that final conclusion requires scientific data.

CanSino agreed in October to supply 35 million doses of the vaccine to Mexico.

(Reporting by Roxanne Liu and Tony Munroe)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In World

Distrust, division and doubt cloud Palestinian election call
Major European powers rebuke Iran over uranium metal plans
Tennis: COVID cases on player flights leave Australian Open buildup in disarray
UK eyes one-off COVID-19 grant instead of permanent benefit hike - Times
In visit to Central African Republic, French general says situation not same as 2013
U.S. state capitals on edge for armed protests as Trump presidency nears end
Explainer: Can Trump pardon himself? Would the courts reject the move?
Iran fires long-range missiles into Indian Ocean in military drill - media
Uganda's Museveni heads for election win, rival alleges fraud
Myanmar police scuffle with nationalist monk's followers

Stories You'll Enjoy